Maruti Suzuki India announces recall of 39,506 Grand Vitara units over fuel indicator issue
Maruti Suzuki India has issued a recall for 39,506 units of its Grand Vitara. The affected vehicles were manufactured between 9 December 2024 and 29...
Get comprehensive coverage of Sectors, including latest updates, analysis, insights, and expert commentary.
Maruti Suzuki India has issued a recall for 39,506 units of its Grand Vitara. The affected vehicles were manufactured between 9 December 2024 and 29...
U.S. Department of Health officials have announced that the COVID-19 vaccine will be available to all citizens free of charge.
Quantas airways sells premium products online as move towards utilizing the spare goodies.
The National Testing Agency has told the Supreme Court that it would not be possible to allot test centres and conduct the NEET (UG) exam overseas.
E-commerce giant AmazonInc said it will launch an online pharmacy in India that will serve the city of Bengaluru, moving to widen its reach in a key growth market.
The Goa state government has decided to exempt 45,000 square meters of land from the proposed new campus of Indian Institute of Technology, Goa.
The Tata Group is expected to make an offer for Air India by the end of the month.
Amazon launched Amazon Pharmacy in India, marking its entry into the online medicine segment.
The ministry of civil aviation and government of Maharashtra gave relaxation on the quarantine norms for Maharashtra that have been framed for preventing further transmission of coronavirus in the state.
Here are the top 10 Business schools in the world to carve out the Corporate professional in you.
Indian Air Force Chief flies MiG-21 Bison at a frontline airbase in the Western Air Command base.
The Department of Telecommunications (DoT) is expected to provide the spectrum waves needed by telecom service providers for testing their 5G networks, by September.
After Russia's launch of the first COVID-19 vaccine, WHO nods approval on any sort of vaccine development and welcomes Russia to try the vaccine on doctors.
India's Zydus Cadila launched the cheapest Remdesivir version of COVID-19 anti-viral to fight the novel Coronavirus.